|
|
I am proud to say that Iberica is built on people. People such as our staff, who have each been selected for their superior skill, dedication and enthusiasm. People such as our Sponsors, who demand the best in development technology and clinical trial management. |
And people such as our volunteers, doctors, co-medical staff and Clinical Research Coordinators who through their kindness and passion ensure that key new therapies successfully reach the people that need them the most the patients. By focusing on the ideal development process from the initial translational research phase through to improving the critical path in later development, Iberica has established itself as an exceptional partner in clinical research development for its Sponsors. Whether it be translational research, developing a drug development plan, the conduct of clinical pharmacology studies, or the conduct of clinical trials in Phases I-IV, Iberica can provide you with the best services to create the scientific evidence you need for registration of your novel or generic therapy, or as a Food for Specified Health Uses (FOSHU). With Iberica, quality and reliability are assured. It also goes without saying that Iberica’s current success would not be possible without the great support and cooperation kindly provided to IBERICA by its various stakeholders. As we continue to strive to meet the current and future needs of Iberica’s stakeholders, I ask for your continued support and cooperation. |
|
Chief Executive Officer Masatomo Abe |
|


